Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
1/29/2026
Phase III Trial Shows Anbenitamab Significantly Improves Survival in H...
1/29/2026
Sciwind Reports Positive Phase III Results for Ecnoglutide in T2DM
1/29/2026
The United Labs Secures U.S. FDA IND Clearance for Novel β-Lactamase ...
1/29/2026
Novartis Wins Expanded China Approval for Leqvio
1/29/2026
NeuShen Thera Raises US$ Tens of Mlns in Series A+ Financing Led by Li...
1/29/2026
Best-Link Bio Raises Over CNY 200M in Series B to Advance Nanoconjugat...
1/29/2026
AstraZeneca Deepens China Commitment With $15B Investment
1/28/2026
ADB Provides CNY 141M Loan to Support China's Community-Based Pharma ...
1/28/2026
China Issues Trial Guidance on Pharmaceutical Research for Preventive ...
1/28/2026
CDE Issues New Technical Guidance for Clinical Trials of Long-Acting L...
1/28/2026
NMPA Releases 101st Batch of Reference Formulations for Generic Drug E...
1/27/2026
CTTQ's TQA3605 Shows Promising Phase 2 Results in Chronic HBV Treatmen...
1/27/2026
China Warns of Foreign Misuse of Research Ties to Access Biological Sa...
1/27/2026
Lisata Regains Greater China Rights to Pancreatic Cancer Candidate Ahe...
1/27/2026
Insilico Expands AI-Driven Cardiometabolic Pipeline with $120M Qilu Co...
1/27/2026
China Releases 2025 Edition Clinical Guidance on the Use of Novel Anti...
1/27/2026
China Issues Revised Implementing Regulations for the Drug Administrat...
1/27/2026
NMPA Adopts ICH M14 Guideline on Real-World Evidence for Drug Safety E...
1/27/2026
Boehringer Ingelheim Strikes €1.05B Deal With Simcere for Preclinical...
1/27/2026
China's Vaccine Market Set for Slow but Steady Growth Through 2035
1/26/2026
CDE Issues Technical Guidance on NMR Studies for Glycoconjugate Vaccin...
1/26/2026
NMPA Suspends Import, Sale and Use of Sun Pharma's Rivastigmine Capsul...
1/26/2026
NMPA Suspends Import and Use of Chlorpheniramine Maleate API from Supr...
1/26/2026
Visen's Lonapegsomatropin Approved in China for Pediatric GHD
1/26/2026
Neowise Raises Over CNY 200M in Series B to Advance TCR-T Therapies fo...
1/26/2026
HealZen Unveils Global Strategic Partnership to Advance Degrader-Antib...
1/26/2026
BMS Accelerates Global Development of PD-L1/VEGF Bispecific After Biot...
1/26/2026
Huahui Wins Conditional Approval in China for First Hepatitis D Therap...
1/26/2026
Dizal Pharma's Hong Kong IPO Application Accepted
1/24/2026
Recent Executive Moves
Page:
1
/
59
Total number of articles:
1759
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit